AZN Astrazeneca Plc

TIDMAZN

RNS Number : 5617K

AstraZeneca PLC

22 September 2016

22 September 2016 11.00

New external board appointment

Listing Rule LR 9.6.14 R (2)

Ann Cairns, a Non-Executive Director of AstraZeneca PLC, is expected to join the Board of Directors of Intercontinental Exchange, Inc., a company listed on the New York Stock Exchange, effective from 2017.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com

CONTACTS

 
 Media Enquiries 
 Neil Burrows          UK/Global                   +44 203 749 5637 
 Vanessa Rhodes        UK/Global                   +44 203 749 5736 
 Karen Birmingham      UK/Global                   +44 203 749 5634 
 Rob Skelding          UK/Global                   +44 203 749 5821 
                                                   +46 8 553 260 
 Jacob Lund            Sweden                       20 
 Michele Meixell       US                          +1 302 885 2677 
 Investor Relations 
 UK 
 Thomas Kudsk 
  Larsen                                           +44 203 749 5712 
                       Finance, Fixed              +44 7881 615 
 Craig Marks            Income, M&A                 764 
                       Respiratory & 
 Nick Stone             Autoimmunity               +44 203 749 5716 
 Henry Wheeler         Oncology                    +44 203 749 5797 
 Christer Gruvris      Infection & Neuroscience    +44 203 749 5711 
 US 
                       Cardiovascular 
 Lindsey Trickett       & Metabolic Diseases       +1 240 543 7970 
 Mitchell Chan          Oncology                   +1 240 477 3771 
 Toll-free                                         +1 866 381 7277 
 

Adrian Kemp

Company Secretary

AstraZeneca PLC

-ENDS-

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNKLLBLQKFXBBF

(END) Dow Jones Newswires

September 22, 2016 06:00 ET (10:00 GMT)

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Jan 2025 to Feb 2025

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Feb 2024 to Feb 2025